Blood Groups and Transfusion Flashcards

1
Q

Why is it important to understand blood groups?

A
  • Safe provision of blood (3million units/year in UK)
  • Preventing and managing transfusion reactions
  • Prevention of haemolytic disease of the new born
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where are red cell antigens found?

A

On surface of red blood cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many blood group systems are there?

A

26

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the most important blood group systems?

A

ABO and Rhesus the most important

As Kell, Duffy, Kidd, MNS etc less likely to cause clinical issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What causes an antibody antigen reaction?

A

Antibody produced by B cells in response to non-self antigens presented to T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What two antibodies produced are important in antibody-antigen reactions?

A
  • IgG antibodies mainly after exposure to blood transfusions or foeto-maternal transmission
  • IgM antibodies occur due to components in food which mimic A and B antigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What structure is human IgM made up of?

A

A pentameric polypeptide chain structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the genetic origin of the ABO system

A
  • FUT1 and FUT2 genes (chromosome19) code for H substance
  • A and B genes (chromosome 9) code for glucosyl transferases which add further sugar groups
  • Naturally occurring anti-A and/or B IgM antibodies in individuals lacking these antigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do ABO antigens differ?

A

In their sugars:

O antigen has a standard antigen with no added sugars

B antigens are O antigens that have undergone the action of a B type enzyme and have galactose sugar added

A antigens are O antigens that have undergone the action of an A type enzyme and have N-Acetylgalactosamine added

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the naturally occurring antibodies present in those with O type blood?

A

Anti-A, Anti-B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the naturally occurring antibodies present in those with A type blood?

A

Anti-B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the naturally occurring antibodies present in those with B type blood?

A

Anti-A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the naturally occurring antibodies present in those with AB type blood?

A

None

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the percentage breakdown of the blood type of the population of the UK

A

O: 46%

A: 42%

B: 9%

AB: 3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How was blood type assessed in the past?

A

On a glass tile they present differently when exposed to anti-A, anti-B and anti-AB antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is blood type assessed now?

A

Using a series of small tubes containing different antibodies, blood that interacts with the antibodies will rise, others will sink (?)

17
Q

What antigens are present in the Rhesus system?

A

c C D e E

18
Q

Describe the Rhesus system

A
  • Antigens c C D e E
  • coded for on chromosome 1 and inherited as a triplet eg cDe
  • ‘Rhesus negative’ implies D negative - other antibodies are referred to less
  • No naturally occurring antibodies but can develop in response to pregnancy or transfusion
19
Q

How does the Rhesus system explain haemolytic disease of the newborn?

A
  • Foetal red cells carrying antigens from the father transferring to maternal circulation
  • Mother produces IgG antibodies to eg D, c, E, Kell
  • Antibodies cross the placenta causing anaemia, jaundice, brain damage or foetal death
20
Q

How do you prevent rhesus D immunisation in pregnant mothers?

A
  • Anti-D prophylaxis given to D negative mothers at 28 weeks and delivery (40 weeks) and after obstetric “events”
  • Kleihauer test looks for foetal cells in maternal circulation (acid elution of Hb- fetal Hb is more resistant –shown on blue arrows
  • Foetal monitoring by ultrasound
  • Can receive intra-uterine transfusion
21
Q

What foetal monitoring occurs in pregnant mothers to screen for haemolytic disease of newborn?

A

Foetus of mother with significant red cell antibodies can be monitored for anaemia eg
Flow in middle cerebral artery Ascites
Liver and spleen size
Umbilical cord sampling for blood count/blood group and antibody level

22
Q

What neonatal management options are there for haemolytic disease of newborn?

A
  • Clinical assessment
  • Blood count and reticulocytes/group/red cell antibodies/bilirubin/direct Coombes test looking for membrane-bound antibody
  • Allow antibodies to decline
  • Phototherapy to increase bilirubin conjugation
  • Top-up or exchange transfusion
23
Q

How is blood cross matched to a patient?

A
  • Donor blood is checked for ABO, rhesus D and often other antigens and the bag is labelled. Also microbiology screening- HIV, Hepatitis etc
  • Recipient’s blood is checked for ABO and rhesus D group and the plasma screened for antibodies against a panel of red cell antigens
  • Recipient’s plasma is mixed with donor red cells to check for agglutination
24
Q

What transfusion reactions can occur?

A
  • Acute haemolytic reactions (pre-existing antibodies) usually due to miss-matched blood, ABO most serious
  • Delayed haemolytic reactions (new antibodies formed following transfusion)
  • Urticaria or anaphylaxis (drugs or plasma proteins)
  • Febrile reactions (HLA antibodies)
25
Q

What are common errors in transfusion?

A
  • Failure to establish patient identity and/or label tube incorrectly when taking blood
  • Lab errors eg incorrect sample used or antibodies not working
  • Failure to perform bedside check of patient identity when administering blood